Ceylinco Healthcare teams up with Apollo Proton Cancer Centre | Sunday Observer

Ceylinco Healthcare teams up with Apollo Proton Cancer Centre

Ceylinco Healthcare Services Limited (CHSL) Chairman R. Renganathan (second from left) and Apollo Hospitals Chairman Dr. Prathap Reddy (centre) exchange the agreement. Looking on (from left) are Medical Director CHSL, Prof. Rohan Jayasekera, CHSL Director Thushara Ranasinghe and General Manager Tharuka de Silva.
Ceylinco Healthcare Services Limited (CHSL) Chairman R. Renganathan (second from left) and Apollo Hospitals Chairman Dr. Prathap Reddy (centre) exchange the agreement. Looking on (from left) are Medical Director CHSL, Prof. Rohan Jayasekera, CHSL Director Thushara Ranasinghe and General Manager Tharuka de Silva.

Proton Therapy, an advanced form of radiation treatment, has become more accessible and affordable for cancer patients in Sri Lanka following the appointment of Ceylinco Healthcare Services Limited (CHSL) as a Medical Affiliate of Apollo Hospitals Enterprise Limited (AHEL) of India, which operates the Apollo Proton Cancer Centre in Chennai, the first and only Proton Therapy facility in the South East Asian region.

A company spokesman said patients undergoing treatment at CHSL’s two radiation treatment centres in Colombo can now be referred to the Apollo Proton Cancer Centre in Chennai if proton therapy is recommended, and undergo treatment at a preferred partner program specified under the agreement between the two institutions.

“We already offer advanced radiation oncology in Sri Lanka via TomoTherapy and Linear Accelerator ensuring patients have the latest and most comprehensive treatment at the most affordable price,” CHSL Chairman R. Renganathan said adding, “We are not providing proton therapy currently or in the near future, and therefore, decided to partner with APCC and provide access to patients who will need this form of treatment.”

The ‘Proton Collaboration Agreement’ entered into by Ceylinco Healthcare Services and Apollo Hospitals Enterprise paves the way for the two institutions to collaborate seamlessly in evaluating patient requirements, referrals to the Apollo Proton Cancer Centre for treatment and post treatment care.

Comments